• slider1
  • slider2
  • slider3
  • slider4
  • slider5
  • slider6

Welcome to

Pacific Biomarkers

About Us  

From Patient to Plate:

Development of Highly Sensitive Clinical PK Assays

Presented by Andrew Macintyre M.D., Ph.D.and Sarah Christensen B.S.

Click here to view the presentation  

Pacific Biomarkers adopts
Cira platform

Pacific Biomarkers will now provide enhanced clinical laboratory services to researchers analyzing biomarkers using the Cira platform.

Read More  

Biomarker Collaboration
Announced:

PBI will provide access to its extensive menu of validated biomarker assays to support WuXi PharmaTech, a leading pharmaceutical company in Shanghai, with integrated clinical trial testing services.

Read More  

Announcing Singulex
Erenna Immunoassay Technology

Pacific Biomarkers announces the expansion of its services portfolio to include ultra-sensitive biomarker assays using the Singulex Erenna Immunoassay technology.

Read More  

Together We Offer More.

The Pacific Biomarkers-Clinigene partnership combines biomarker support for clinical trial research of the former with development capabilities of ligandbinding assays of the latter in a cost-effective business model situated in India.

Learn More  

Pacific Biomarkers has provided clients with specialty biomarkers services for more than 20 years, and has one of the largest biomarker libraries in the industry.  Read More

Biomarker Menu Search:

From Patient to Plate:

Development of Highly Sensitive Clinical PK Assays. Presented by Andrew Macintyre M.D., Ph.D.and Sarah Christensen B.S.

View presentation  

New Partnership:

Pacific Biomarkers and Clinigene: Together We Offer More.

Learn more about this partnership  

Loading Tweets...